Exploring the causal influence of 731 immune cells on 4 different glaucoma subtypes using a two-sample mendelian...

Area of Science:

• Immunology
• Ophthalmology
• Genetics

Background:

• Glaucoma progression involves ocular nerve damage and immune responses.
• Activated immune cells, including T cells, B cells, and macrophages, can exacerbate glaucoma.
• Understanding these immune cell roles is crucial for developing targeted treatments.

Purpose of the Study:

• To investigate the causal relationships between various immune cells and four glaucoma subtypes.
• To identify specific immune cell types associated with neovascular glaucoma (NVG), primary open-angle glaucoma (POAG), primary closed-angle glaucoma (PACG), and normal-tension glaucoma (NTG).
• To provide evidence for developing personalized immunomodulatory and immunosuppressive therapies for glaucoma.

Main Methods:

• Employed five Mendelian randomization (MR) methods: inverse variance weighted (IVW), MR-Egger, simple model, weighted median, and weighted mediation model.
• Utilized glaucoma Genome-Wide Association Study (GWAS) data from FinnGen.
• Incorporated summary statistics for immune cell phenotypes from the GWAS catalogue.

Main Results:

• Identified significant causal relationships between numerous immune cell types and glaucoma subtypes.
• Found 21 immune cell types causally linked to NVG.
• Found 37 immune cell types linked to POAG, 40 to PACG, and 24 to NTG.

Conclusions:

• The study establishes a causal link between specific immune cells and different glaucoma types.
• Results highlight the potential for immune cell profiling in diagnosing and treating glaucoma.
• Findings pave the way for novel, personalized immunotherapies in glaucoma management.